Submitted by Anonymous (not verified) on 12 October 2023 - 16:31
Human medicines European public assessment report (EPAR): Sugammadex Adroiq, sugammadex, Neuromuscular Blockade, Date of authorisation: 26/05/2023, Revision: 1, Status: Authorised
Source: